Women are born with roughly one to two million immature eggs, and that number only goes down from there. Before birth, the count is even higher, peaking at several million during fetal development before a wave of natural cell death trims it dramatically. By puberty, somewhere around 300,000 to 400,000 eggs remain. Over a reproductive lifetime, only about 400 to 500 of those will actually be released through ovulation. The rest disappear through a steady, largely invisible process that accelerates as a woman ages and ultimately ends at menopause.
Where the Eggs Come From
Egg cells begin forming early in fetal life. Primordial germ cells migrate to the developing ovaries and begin dividing rapidly, eventually entering the early stages of cell division called meiosis. At that point they become oocytes, and they lose the ability to multiply further. These oocytes pause in a suspended state of development and remain frozen there, sometimes for decades, until hormonal signals coax individual ones to resume maturing much later in life.
The peak egg count happens before a girl is even born, around the fifth month of fetal development, when the ovaries may contain six to seven million potential egg cells. But a massive die-off begins almost immediately. By birth, most of those cells have already been eliminated through programmed cell death, leaving the one to two million that a newborn girl carries into the world.1PubMed Central. Establishment of oocyte population in the fetal ovary: primordial germ cell proliferation and oocyte programmed cell death This is a one-way trip. The conventional understanding, supported by decades of research, is that no new eggs are produced after birth. What you start with is what you get.
The Lifelong Decline in Numbers
From birth onward, the egg supply drops continuously. The loss isn’t linear. It follows a curve that starts relatively gentle and steepens over time. A large modeling study that pooled data from multiple histological investigations estimated that by age 30, only about 12% of a woman’s maximum pre-birth egg population remains. By age 40, only about 3% is left.2PubMed Central. Human ovarian reserve from conception to the menopause Those percentages sound alarming, but remember they’re measured against that fetal peak of several million. At 30, a woman may still have tens of thousands of eggs. At 40, the number is considerably smaller but not zero.
The rate of loss accelerates noticeably in a woman’s mid-to-late thirties. Research has shown that once the follicle pool drops below a certain threshold, the remaining follicles disappear faster. When the count falls to roughly 1,000, menopause arrives, and the median age for that in the general population is around 51.3Human Reproduction. Accelerated disappearance of ovarian follicles in mid-life: Implications for forecasting menopause So while the decline feels gradual for most of a woman’s twenties, the final stretch compresses dramatically.
Why Most Eggs Never Get a Chance
Each menstrual cycle, a group of dormant follicles is recruited and begins growing. Of that group, typically only one follicle “wins” the hormonal competition to become the dominant follicle, the one that will go on to ovulate. The rest of the recruited follicles simply die off.4PubMed. Observations in favor of normal early follicle development and disturbed dominant follicle selection in polycystic ovary syndrome This means that for every egg released during ovulation, dozens more are lost in the same cycle. Over roughly 30 to 40 years of menstrual cycles, a woman ovulates only about 400 to 500 eggs total. The overwhelming majority of her original supply is eliminated without ever leaving the ovary.
When that dominant follicle is ready, a surge of luteinizing hormone triggers a cascade of events inside the ovary. The follicle wall breaks down through enzymatic and inflammatory-like processes, the surrounding tissue reorganizes, and the mature egg is released into the fallopian tube.5Endocrine Reviews. Ovulation: Parallels With Inflammatory Processes The process is sometimes described as a controlled rupture, which is a fairly accurate way to picture it. If the egg isn’t fertilized, it disintegrates within about 24 hours.
What Kills the Eggs That Don’t Ovulate
The main mechanism behind egg loss is follicular atresia, a process where follicles degenerate and are reabsorbed by the body. This isn’t random damage. It’s a regulated biological program driven by specific forms of cell death. The best-studied pathway is apoptosis, sometimes called programmed cell death. In atretic follicles, the granulosa cells that surround and support the egg begin to break apart in a characteristic pattern: they detach from the follicle wall, their DNA fragments into a distinctive “ladder” pattern, and the follicle collapses.6PubMed. Biochemical identification of apoptosis (programmed cell death) in granulosa cells: evidence for a potential mechanism underlying follicular atresia
Research has identified specific molecular pathways that drive this process. One involves the p53 protein and the Fas signaling system, both of which are well-known regulators of cell death in other tissues. In follicles destined for atresia, granulosa cells show increased activity of these death-promoting proteins, their cell cycle stalls, and they eventually self-destruct.7PubMed. Involvement of the Fas/Fas ligand system in p53-mediated granulosa cell apoptosis during follicular development and atresia More recent work has expanded the picture beyond apoptosis to include other forms of regulated cell death, like autophagy and ferroptosis, which appear to play overlapping roles in follicle elimination.8PubMed Central. Mechanisms of follicular atresia: focus on apoptosis, autophagy, and ferroptosis When these processes go wrong, they can contribute to reproductive problems, but under normal circumstances they serve as quality control, clearing out follicles that didn’t receive the right hormonal support.
The Quality Problem
Declining egg numbers are only half the story. Egg quality also drops with age, and for many women this is the more consequential change when it comes to fertility. The eggs a 38-year-old has left are not simply fewer versions of the eggs she had at 25. They are biologically different, and more likely to have problems.
One major issue involves structures called cohesins, protein rings that hold paired chromosomes together inside the egg. Cohesins are loaded onto chromosomes before birth and, critically, cannot be adequately replaced afterward. Over decades of sitting in that suspended state, cohesin proteins gradually degrade. Without them, chromosomes are more likely to separate unevenly when the egg finally completes its division, producing eggs with the wrong number of chromosomes.9PubMed Central. Deterioration without replenishment–the misery of oocyte cohesin This is the primary reason chromosome abnormalities like trisomy 21 (Down syndrome) become more common with maternal age. The eggs aren’t “wearing out” in some vague sense; they’re losing a specific structural component that was installed in fetal life and never refreshed.
Mitochondrial function is the other piece. Eggs contain far more mitochondria than any other cell in the body, reflecting the enormous energy demands of early embryo development. As eggs age, their mitochondria accumulate damage, produce energy less efficiently, and generate more harmful byproducts.10PubMed. Mitochondria: Their relevance during oocyte ageing Research consistently links this mitochondrial decline to poorer outcomes in fertilization and early embryo development.11PubMed Central. The contribution of mitochondrial function to reproductive aging Together, cohesin decay and mitochondrial dysfunction explain why fertility drops sharply in the late thirties and early forties even in women who still have a reasonable number of eggs remaining.
How Doctors Estimate What’s Left
You can’t directly count the eggs inside a living woman’s ovaries. Instead, clinicians use indirect markers that correlate with the remaining follicle pool. The two most widely used are AMH (anti-Müllerian hormone) and antral follicle count.
AMH is a hormone produced by the granulosa cells of small growing follicles. Its blood level roughly tracks the size of the remaining follicle reserve, and it can be measured with a simple blood draw on any day of the menstrual cycle.12PubMed Central. Anti-Müllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function Antral follicle count involves a transvaginal ultrasound to count the small follicles visible at the start of a cycle. Both markers show progressive declines with age that mirror the pattern of actual egg loss seen in tissue samples. AMH and antral follicle count decline at accelerating rates: at age 30, the average yearly drop is modest, but by 40, the rate of decline has roughly doubled or tripled.13PubMed Central. A characterization of the relationship of ovarian reserve markers with age
One important caveat: AMH and follicle count tell you about quantity, not quality. A 42-year-old with a high AMH level still faces the age-related quality issues described above. Conversely, a 28-year-old with a lower-than-expected AMH may still have excellent egg quality. These tests are most useful in the context of fertility treatment, where predicting how many eggs can be retrieved in a given cycle directly affects treatment planning. An antral follicle count above a certain threshold has been shown to predict oocyte retrieval with high reliability.14PubMed Central. Value of the Ultrasound in the Study of Ovarian Reserve for Prediction of Oocyte Recovery But these numbers don’t tell the whole fertility story on their own.
The rate of AMH decline also varies between individual women. A large population-based study found that while the overall trend accelerated after age 40, the trajectory wasn’t the same for everyone. Some women showed steeper drops earlier, while others maintained higher levels longer.15PubMed Central. Back to the basics of ovarian aging: a population-based study on longitudinal anti-Müllerian hormone decline This individual variation is part of why blanket age-based predictions about fertility can be misleading.
What Speeds Up the Loss
Several external and medical factors can accelerate the depletion of ovarian reserve beyond what age alone would predict.
Smoking is one of the best-documented lifestyle factors. Among women seeking fertility care, each additional cigarette smoked per day was associated with roughly an 8% increase in the odds of diminished ovarian reserve, and a similar dose-response was seen with lifetime pack-year exposure. The strongest effects appeared in women smoking at least ten cigarettes a day or with more than five pack-years of total exposure.16PubMed Central. Association between cigarette smoking and ovarian reserve among women seeking fertility care The toxic compounds in cigarette smoke appear to directly damage ovarian follicles and speed up the same apoptotic processes that cause natural atresia.
Chemotherapy is a more dramatic threat. Certain drugs, particularly cyclophosphamide, are highly toxic to the ovary. They cause DNA damage in the oocytes of resting follicles, triggering massive apoptosis within hours. The result can be a rapid and sometimes permanent depletion of the follicle reserve, effectively pushing a young woman into early menopause.17PubMed Central. Ovarian damage from chemotherapy and current approaches to its protection Other chemotherapy agents like doxorubicin work through similar mechanisms, inducing DNA double-strand breaks that can destroy primordial follicle oocytes within 12 to 24 hours of exposure.18PubMed Central. Unraveling the mechanisms of chemotherapy-induced damage to human primordial follicle reserve: road to developing therapeutics for fertility preservation and reversing ovarian aging Pelvic radiation has comparable effects. This is why fertility preservation through egg or embryo freezing is routinely discussed with young cancer patients before treatment begins.
Genetics and the Timing of Menopause
Not every woman loses eggs at the same rate, and genetics play a meaningful role in determining when the supply runs out. Large genetic studies in women of Northern European ancestry have identified hundreds of genetic variants associated with the age at which menopause occurs. These variants tend to cluster in genes involved in DNA repair, mitochondrial function, and immune regulation, all of which fit with what we know about how follicles are maintained and lost.19PubMed Central. Shared Genetics Between Age at Menopause, Early Menopause, POI and Other Traits
What makes this interesting is that the same genetic factors appear to connect menopause timing to other health outcomes, including breast cancer, ovarian cancer, bone density, and type 2 diabetes. This doesn’t mean early menopause causes those conditions or vice versa, but it suggests they share underlying biological pathways. A woman whose genetics predispose her to earlier follicle loss may also carry variations that affect how her body handles DNA damage throughout life. The practical takeaway is that family history of early menopause is one of the better informal predictors of your own reproductive timeline.
Egg Freezing and Working Around the Clock
The development of oocyte cryopreservation, commonly called egg freezing, has given women a way to partially sidestep the biological clock. The technique involves stimulating the ovaries to mature multiple eggs in a single cycle, retrieving them, and freezing them for later use through a rapid-cooling process called vitrification.
The technology has improved substantially over the past decade. Studies comparing outcomes between fresh and frozen-thawed eggs used in fertility treatment have found comparable fertilization rates and pregnancy rates, and there is no evidence of increased birth defects in babies conceived from vitrified eggs.20PubMed Central. Oocyte Cryopreservation – Current Scenario and Future Perspectives: A Narrative Review The catch is that the eggs need to be healthy when they’re frozen. A batch of eggs frozen at 32 will generally be of higher quality than a batch frozen at 39, because of the cohesin and mitochondrial issues that accumulate with age. And the number of eggs retrieved in a single cycle tends to be lower in older women, sometimes requiring multiple retrieval rounds.
Egg freezing doesn’t guarantee a future pregnancy. Not every frozen egg survives thawing, not every surviving egg fertilizes, and not every embryo implants. But it does offer insurance against the one-way trajectory of ovarian aging, and it’s increasingly common among women in their early-to-mid thirties who want to preserve future options.
Can Women Make New Eggs?
For over a century, the dogma in reproductive biology has been clear: females are born with all the eggs they’ll ever have, and no new ones are produced after birth. In 2004, a research group challenged this idea by reporting evidence of mitotically active germline stem cells in the postnatal mouse ovary, suggesting that the mammalian ovary might be capable of generating new oocytes in adulthood.21PubMed Central. Making eggs: is it now or later?
The claim sparked an intense and ongoing debate. Some labs reported isolating similar cells from human ovarian tissue, while others failed to replicate the findings or questioned whether the isolated cells could truly produce functional eggs. As of now, the mainstream consensus has not shifted. The practical reality for women making reproductive decisions is still that the egg supply is finite and non-renewable. If future research were to establish a reliable way to generate new oocytes from stem cells, it would fundamentally change reproductive medicine. But that remains a frontier, not a clinical option.
Why the Numbers Are Rougher Than They Sound
You’ll often see precise-sounding figures quoted online: “women are born with exactly one million eggs” or “you lose 1,000 eggs per month.” These numbers are rougher estimates than they appear. The original histological studies that established the counts were done on relatively small numbers of ovarian tissue samples, and there’s natural variation between women. The modeling study that estimated 12% remaining by age 30 and 3% by age 40 explained most but not all of the variation in the data, particularly in women over 25.2PubMed Central. Human ovarian reserve from conception to the menopause The general shape of the decline is well established. The exact numbers at any given age for any individual woman are not. Two women of the same age can have very different reserves, influenced by genetics, medical history, lifestyle, and factors we probably haven’t identified yet.
This matters because the numbers are often used to create urgency, sometimes justified and sometimes not. A healthy 33-year-old reading that she’s already lost 88% of her eggs might panic unnecessarily. That percentage, while real in aggregate, doesn’t tell her how many eggs she personally has left or how fertile those eggs are. The trajectory matters more than any single snapshot, and individual variation is wide enough that population averages can be genuinely misleading when applied to one person’s body.